WASHINGTON (dpa-AFX) - Novo Nordisk announced that the US Food and Drug Administration has approved the Biologics License Application for Esperoct for the treatment of adults and children with hae...
Original Article: FDA Approves Novo Nordisk's Esperoct To Treat Haemophilia A